Clinical Trial Update: A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component Strep A Vaccine With Aluminum Hydroxide (Alum) or AS37 in Healthy Young Adults [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate safety, reactogenicity, and immunogenicity of GlaxoSmithKline's 4-component Strep A vaccine in healthy young adults, with Aluminium hy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Streptococcal Infections

Drugs mentioned

• GSK 4-component Strep A vaccine with AS37 adjuvant
• GSK 4-component Strep A vaccine with Aluminum Hydroxide (Alum)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Streptococcal Infections | Phase 1 | Status: RECRUITING